January 27th, 2012

VTR and REITs: Awaiting Resolution of “Great Convergence”

As discussed in the previous post, the market is at a crucial juncture, something I have labelled “The Great Convergence”.  The confluence of risk and opportunity is seldom as obvious as it is today.  Many of the risks still hang over our heads (need I mention Europe sovereign debt, U.S. election season, renewed U.S. budget debates, housing market still on its back, another round of debate about healthcare, etc.) yet each, through the prospect of their ultimate resolution, presents impetus offers another reason to be bullish.

The Convergence is evident as the apex of the huge symmetrical triangle that has formed over the past 4-5 years in chart of the S&P 500 Index since 2007.

One sector that safe for waiting for more certainty are the REITs.  With the Fed announcing that they foresee low interest rates through 2014, the yields available in REITs still looks competitively attractive, even though the stocks continue to appreciate without any significant correction.  One stock that seems to fit that description is VTR (Ventas Inc).  With a dividend yield of 3.9%, VTR appears to be a stock in which one can sit and wait until the direction out of the Great Convergence is clear.

Rather than mimicking the chart of the S&P 500, VTR recently broke above a significant 5-quarter resistance trendline.  That may be considered a consolidation cup-and-handle after the long run from the reversal pattern at the bottom of the Financial Crisis Crash.  If it turns out to actually be a consolidation, then the next move could take the stock up to around 100 using the charting rule-of-thumb that a consolidation is at the mid-point of the move (the move after the consolidation should approximately equal the move before):

Technorati Tags: , ,

December 7th, 2011

New Highs + Dividends; Unbeatable In This Market?

I know it’s frustrating having to sit around waiting for the market to show its hand as to future direction.  But for me, it’s the cautious and prudent thing to do.  I’ve just been disappointed and have lost too much in the past by thinking I can pick the few stocks that are able to hold their own against the forces of a declining market.  But I am beginning to put together a watchlist of stocks with interesting technicals but have decided not acting on them yet.

One place I began my search is to comb through stocks that are in all-time new high territory (because of system limitations, I’m limited to stocks moving to new 5-year highs as a surrogate metric).  A measure of how poorly stocks have performed over the past 18 months is the fact that only 118, or 2.4% of all stocks, meet the criteria. The distribution of these 118 stocks by Industry Group includes:

Stocks in All-time New High Territory by Industry Group 12/07/11

Not knowing how long it will be before the market gained some upward momentum, I decided to zero in first on the stocks paying the largest dividends.  For those itching to hit that “Buy” button, here are a few stocks I came up with you might be interested in:

Top Dividend Payers + All-Time New Highs 12/07/11

Dividends and continuing their ascent into all-time new high territory.  Almost an unbeatable combination?

May 12th, 2011

Sell Rule: Out-of-Favor Industry Groups

A mistake most traders, including myself, often make is focusing too much on what is or, more correctly, what will in the near future be moving higher. In the Weekly Recap Report I send to subscribers, I include both an breakdown by industry group of stocks in the current Portfolio as well as a list of Investors’ Business Daily’s top-ranked Industry groups and Groups moving up in rank the most during the past 3 months.

Our goal is finding tomorrow’s hot stocks. At the same time, however, we should make sure that the stocks we already have in our portfolios continue performing. It’s just as important to see what Industry Groups are falling the most in their rankings as it is those that are rising the fastest.

For example, I’ve been beating the drum for healthcare related Industry Groups for some months and, as of this past weekend, over 20% of the portfolio is now made up by stocks in those groups; most have performed extremely well. I included the following chart in a recent Recap Report of the Medical-Biomed/Biotech ranking showing that these stocks, as a group, have been among the best performers for over a year (click on images to enlarge):

What I hadn’t looked at or acted on was the other end of the spectrum – the industry groups that might have been falling fastest. If I had, I would have seen, for example, was that all the Oil & Gas related Industry Groups had begun losing their top rank positions. I had blinders on but if I had looked at the other end, I would have seen the stocks that were dropping the most in ranking. I would have seen groups like the Oil & Gas-International Exploration and Development:

and the Oil & Gas – Canadian Exploration and Development:

Both of these groups had started turning down from their top rankings in mid-March and were now among the lower half in ranking of the 197 Industry Groups; both were now clearly under the 20-week moving average of their ranking. If I had taken notice and acted as quickly to dispose of these stocks in the Portfolio as I was adding healthcare stocks then I would have preserved a lot of profit.

Last November, I wrote “My Sell Rules Discipline” in which one rule is selling “individual stocks where risks associated with that stock appear to have increased”; the fourth example is “an industry group if it falls out of favor”. I just didn’t follow my own rules. I have long known that Industry Group factors contribute about 30% to a stock’s movement (the market is 50% and factors related exclusively to the individual stock contribute the remaining 20%). What I just now re-learned, a lesson I won’t soon forget, is that we have to look not only for new stocks to add but also to find and quickly act to prune out stocks in Industry Groups out of which money clearly is flowing.

April 1st, 2010

Boomer Impact on Health Care Services and Products

Hope you noticed I was AWOL for a week but it was for a valid, even if mournful, reason. My mother passed away last week after a relatively long and painful battle against the ravages of late-stage osteoporosis. It’s not often that someone writes a eulogy in a stock investment blog but I thought I would because its what she might have appreciated (her final wish was “to be remembered”). And now, through technology and the power of the Internet, she will be.

My mother was a vital 96 when she passed away. But her age wasn’t the most amazing thing about her. Perhaps the second most amazing thing was that for 71 years she put up being married to my father and living in his shadow. He will soon have his 98th birthday.

Perhaps the best description of my mother, one written by my son on his website, a succinct description I dare not compete with, follows:

Lillie (1913-2010)
My grandmother was a really cool and special lady.
She grew up very poor in Hungary.
She outwitted the Nazis to survive WWII.
She found her way to America and loved it here.
She wrote about it all in her memoirs.
She was married for 71 years!
She cooked incredible stuffed cabbage and squeezed her own orange juice.
She played Uno and Rummikub with us.
She always hung my drawings on the refrigerator.
She was the best grandmother you could ever have and I’m gonna miss her.

Now back to the mundane business of stocks.

Spending last week in Sun City, Arizona brought home something I knew intellectually but hadn’t focused sufficiently on: the economic impact of an aging Boomer Generation. You could rightly say, “Duh!” But it’s not until I accompanied my dad to one of his unfortunately all too regular clinic visits for blood tests that it sank in.

With an excellent hospital and extensive health services of every imagined variety, the area is very “grey-centric” and, yet, we still waited 40 minutes for a simple blood test. The waiting room was filled to capacity, getting copies of test results was complicated and the various physicians, services and records were geographically dispersed.

What’s going to happen to all these facilities and services when the patient begins growing exponentially as Boomers move into their senior years? Inevitably the same thing that happened when they moved into elementary school, into high school, into college and then into the real world of marriage, babies of their own and the work force. The answer is that Boomers will put the same squeeze on health care capacity as they have every other system as they passed through various life phases.

O.K., that’s what the health care debate has been all about, I’ll grant you that. But you can look on this as a bricks-and-mortar and “labor” constraint challenge, as well. There just won’t be sufficient capacity in the system to handle the bulge in the same way that there weren’t enough school rooms, houses, cars, etc.

Which leads me to reaffirm my conviction that most stocks in the health care industry, whether in medical technology, hospital operation and ownership, health insurance, financial services, nursing homes, retirement communities, etc. should appreciate substantially over the next 15 years. Many have offered the analogy of a python swallowing a pig to the effect Boomers have had on stocks of companies that benefited as they moved through their various life phases. They are approaching retirement and all these industries and stocks will likewise change and benefit (see “More Health Care Stocks” of March 22).

March 23rd, 2010

More Health Care Stocks

It’s been building for a few months but now that it seems the health care bill has passed and is about to be signed into law, a wide range of health service related stocks look like they’re perking up and are about to make some headway.

We were premature but saw the opportunity in the making for these stocks then but they look prime now. In addition to the three identified in “HMO Stocks: AET, UNH and WLP” on December 10 can now be added hospital, nursing home and outpatient/homecare stocks. Those in the groups that appear to me to have clear, strong, long bases or consolidation patterns include (click on image to enlarge):

  • DVA (Davita)
  • GTIV (Gentiva)
  • LCAV (Lca-Vision)
  • DCAI (Dialysis Corp)
  • BKD (Brookdale)
  • KND (Kindred)
  • SRZ (Sunrise Senior)
  • ENSG (Ensign)
  • THC (Tenet)
  • CYH (Community)
  • UHS (Universal)
  • LPNT (Lifepoint)

I couldn’t include all the charts due to space and time constraints. The above are included only on the merits of their charts; you should, as usual, do your on diligence in evaluating these and other stocks based on both their technical and fundamental merits for your own portfolio and investment style.

December 10th, 2009

HMO Stocks: AET, UNH and WLP

Even the best in sports needs coaching from someone who can give them objective feedback and playing the stock market game as an individual investor is no exception. A long-time reader and someone I’ve been mentoring since the last summer’s start, let’s call him Eric, alerted me to an industry group with charts that have many of the same characteristics as the general market had when we saw the inverted head-and-shoulders in the S&P 500 Index. One knows they’ve done an excellent job of mentoring when the mentee teaches the mentor.

This was recently brought home to me when Eric suggested I take a look at WLP (Wellpoint), a member of IBD’s Medical-Health Maintenance Organization Industry Group. The last time I wrote about medical stocks was on February 4, when I wrote:

“Will market participants see all this resistance overwhelming or will traders large take a move towards and above each one of these obstacles (along with favorably received Government action) be a signal for more money to be moved out of Treasuries and into riskier equities.

While still mostly on the sidelines myself (80% in cash), I have edged out into some equities. I’m always on the lookout for more stocks with good charts that also have met or are close to meeting the additional criteria of have a “golden cross”. Many of these stocks happen to be in the defensive healthcare industry groups like pharma, drugs and biotech.”

Charts included in the post were

  • MTXX (then 18.19 but trashed in June due to having to pull Zycam from the market),
  • SIGA (then 4.02, yesterday 8.66, or 215%),
  • CMN (then 14.68, yesterday 19.45 or 133%) and
  • SXCI (then 20.00, yesterday 52.02, 260%)

Oh, if I had just followed my own advise and stuck with those recommendations. But there may be another opportunity (albeit, with the market’s completely different backdrop … anticipating a correction rather than anticating the recovery) among the 15 HMO stocks. Some have experience significant appreciation since March 5 like CVH (178%), CI (160%) or HNT (108%). But these three (including Eric’s WLP) caught my eye as group members that have a good chance, with what appears as debate on the healthcare approaching some closure, to begin finally to follow the herd:

  • AET (Aetna)
  • UNH (United Health)
  • WLP (Wellpoint)

February 4th, 2009

Healthcare: MTXX, SIGA, CMN and SXCI


Well, at least one day down and the bottom-boundary trendline of the symmetrical triangle held support. A few more days like yesterday and I’ll next be writing about the outlook for breaking above the upper-boundary trendline. That area is really interesting since so much is converging in that ara:

  • the upper boundary of the symmetrical triangle
  • the upper boundary of a steep downward-sloping channel covering the worst of last year’s bear market crash going back to last August
  • the 60-day moving average and
  • not too much higher (around 4%), the 90-day moving average

Will market participants see all this resistance overwhelming or will traders large take a move towards and above each one of these obstacles (along with favorably received Government action) be a signal for more money to be moved out of Treasuries and into riskier equities.

While still mostly on the sidelines myself (80% in cash), I have edged out into some equities, many also in the Model Portfolio. But I’m always on the lookout for more stocks with good charts that also have met or are close to meeting the additional criteria of have a “golden cross”. Many of these stocks happen to be in the defensive healthcare industry groups like pharma, drugs and biotech. Examples include:

  • MTXX (Matrixx Initiatives)

  • SIGA (Siga Pharma)

  • CMN (Cantel Medical)

  • SXCI (SXC Health Solutions)

Note: We’re going to be having some escapee’s from the cold Northeast visiting with us here in FL (also colder than usual) for a few days so my postings will be spotty. Hope to be back with a steady stream of charts and market analysis by Monday.

January 16th, 2009

Cramer and IBB and CELG

Such condescension. Why can’t Cramer just understand that others aren’t necessarily wrong, they just might be a different opinion than his. Oh, I know why. It’s because he might then have to admit fallibility.

Take, for example, his latest Tech vs. Fundamental rap last night – this time about biotechs. Quoting from the recap on the MadMoney CNBC website (all emphasis are mine):

  • “one school of investing often sees what the other doesn’t”. Shouldn’t that be one school of investing often sees things differently than the other”?
  • According to Cramer, IBB (the biotech ETF) “is a sell, at least from a technician’s perspective. A look at the chart shows that IBB’s uptrend line is broken, meaning the ETF’s rate of ascent has changed. Put simply, the momentum’s gone because there are more sellers than buyers right now. When this happens in a group as beloved as the biotechs, it usually indicates that the good news is priced in and a decline is coming. So investors should get out.” ….. The uptrend line he talks about is so short-term that breaking it is meaningful only to daytraders. What about a longer perspective? That trendline is merely a squiggle in a long-term base going back to October that IBB is forming along with the market, other industry groups and individual stocks.
  • Cramer goes on to say that “On the fundamentals side, though, the explanation’s not so easy.” Implying that the technical perspective is simplistic and as simple as drawing a trendline or moving average – any trendline and any moving average – and buying or selling if the price moves above or below it. Cramer, you simpleton, IT’S NOT THAT SIMPLE.
  • Setting the stage for pumping the stock he has a vesting interest in, he says “the key is to select specific names from among the group.” He then touts his stock Celgene (CELG) on fundamental reasoning and sums up by saying “The charts say sell, but the fundamentals look good to Cramer. Especially CELG, he said, the best and cheapest in the group.”

No let me paint a different technical picture. First, because of the huge market shock that we suffered in 2008 and may still not you be recovering from it’s important to view all charts from a much longer perspective – perhaps all the way back to 200-03, the last time the market has been so beating up (see my various previous posts comparing the current bear market crash with the Tech Bubble Crash). When viewed through binoculars rather than microscope, IBB presents a much different picture:

The industry never regained its footing after the Tech Bubble Crash (similar to but less dire than the semiconductor industry – see the SMH etf). IBB has a very clear upper-boundary resistance trendline connecting 5 peak pivot points. Until the current market crash, the etf reflected down to a lower boundary support trendline (depicted as a dashed line) connecting 4 trough pivot points. The downdraft of the 2008 market crash caused the etf to break that lower trendline to rest on a potential new lower boundary support trendline that’s nearly perfectly parallel to the upper boundary (a common phenomena in upward channels, whether upward-, downward- or horizontal).

So forget Cramer’s broken uptrend trendline. All that can be said is that it’s attempting to form a base from which it will bounce off the bottom trendline along with the market’s recovery. If the market fails, then IBB will break through the support trendline and could fall to the low-40′s.

What about Cramer’s “favorite”, Celgene (CELG)? No question if you owned the stock since the Tech Bubble Crash bottom you owned a rocket that went up nearly 20-fold to 2007. Rather than collapsing during the 2008 Credit Crises Crash, it has also formed an upward sloping channel:

Will this 2007-08 price action turn into a reversal pattern or will it prove to be a continuation (consolidation) pattern. Cramer is confident (as he always is) he knows the answer and that this is a way station and the stock will continue its rocket ride as the market improves (or regardless of whether the market and economy improves or not).

But as an individual investor I could spend hours reading reports, listening to conference calls, hearing management at their annual meeting and I still wouldn’t know whether the share price growth will continue. I’m not even sure momentum will ever return in the same way. I’d rather wait to let others (buyers and sellers) fight it out and I’ll get on the bandwagon once it breaks out of this range.

July 15th, 2008

Healthcare Products Industry

Yesterday was a truly awful day today, the absolute definition of the words “whipsawed” and “rotation”. Take a look at the intraday S&P 500 chart:

The Index had a 2.8% move from its low of 1200 to it’s high of 1234; it closed with a 1.09% decline for the day.

And for rotation, check out the almost instantaneous revaluation of energy stocks. From near the open until around 11:30, oil & gas stocks dropped dramatically. Typical was the iShares US Oil & Gas Exploration and Producer etf:

The explanation for the liquidation in this industry group is that banks and other financial institutions were selling their oil & gas stocks to generate some liquidity. Who says that herd doesn’t run together.

And to where did they run? One industry that seemed to benefit was the medical products stocks as represented by the iShares DJ US Medical Devices etf:

For the first time since the 1990′s, the weighting of Healthcare stocks exceeded Financial stocks in the S&P 500 Index. Some of the names that look like they’re positioning themselves to break to the upside include:

  • ABMD (Abiomed)
  • EXAC (Exactech)
  • MMSI (Merit Medical Systems)
  • QDEL (Quidel)
  • KNSY (Kensey Nash)
  • VITL (Vital Signs)
  • NUVA (Nuvasive)
  • ACL (Alcon)

Get your little toe into this sector only without losing sight of your longer-term and overall view of the market’s general trend which still points down.